
Brooks Laboratories Ltd is Rated Sell
2026-05-20 10:10:56Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Brooks Laboratories Ltd Locks at Upper Circuit With 4.53% Gain — Buyers Queue, Sellers Absent
2026-05-19 14:00:07At Rs 48.42, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.53% on 19 May 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Brooks Laboratories Ltd Locks at Upper Circuit With 3.88% Gain — Buyers Queue, Sellers Absent
2026-05-12 11:00:05At Rs 49.83, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 3.88% on 12 May 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Brooks Laboratories Ltd Locks at Lower Circuit With 3.06% Loss — Sellers Queue, No Buyers in Sight
2026-05-11 12:00:08At Rs 48.4, Brooks Laboratories Ltd locked at its lower circuit on 11 May 2026, reflecting a 3.06% decline within a 5% price band. Despite sellers lining up to exit, there were no buyers willing to absorb the supply, resulting in a freeze at the floor price and unfilled sell orders that highlight the stock’s current liquidity challenges.
Read MoreBrooks Laboratories Ltd Falls 8.44%: 3 Key Events Shaping the Week
2026-05-09 17:02:59Key Events This Week May 4: Brooks Laboratories Ltd hits upper circuit amid strong buying pressure May 6: Stock surges again to upper circuit, reversing six-day losing streak May 8: Heavy selling drives stock to lower circuit limit Week OpenRs.55.59 Week CloseRs.50.90-8.44% ...
Read More
Brooks Laboratories Ltd is Rated Sell
2026-05-09 10:10:36Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Brooks Laboratories Ltd Locks at Lower Circuit With 4.99% Loss — Sellers Queue, No Buyers in Sight
2026-05-08 13:00:06At Rs 49.93, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 4.99% on 8 May 2026, with unfilled sell orders and a frozen price that capped losses for the session.
Read More
Brooks Laboratories Ltd Locks at Upper Circuit With 4.94% Gain — Buyers Queue, Sellers Absent
2026-05-06 13:00:07At Rs 56.97, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.94% on 6 May 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Brooks Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-05-04 13:00:06At Rs 58.77, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.98% on 4 May 2026, with buyers queuing and no sellers willing to part with shares.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
30-May-2026 | Source : BSENewspaper Publication dated 30th May 2026 of Audited Financial Results for the quarter and year ended 31st March 2026.
Results-Financial Results For March 31 2026
29-May-2026 | Source : BSEOutcome of the Board Meeting held on Friday 29th May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
29-May-2026 | Source : BSEAnnual Secretarial Compliance Report of the financial year ended 31st March 2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Brooks Laboratories Ltd has announced 1:16 rights issue, ex-date: 28 Jul 23